Sign in
4

Changes in Ownership

TriSalus Life Sciences, Inc. Filed Acc 0001415889-24-003821

CEO AND PRESIDENT acquired 84,899 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Szela Mary T CEO AND PRESIDENT 2024-02-13 Grant or award +84,899 364,862 D
Derivatives
Szela Mary T CEO AND PRESIDENT 2024-02-13 Grant or award · Employee Stock Option (right to buy) +288,750 288,750 D
Loading xslF345X05/form4-02142024_110233.xml…